Tazarotene Completed Phase 2 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02785159Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis